407 related articles for article (PubMed ID: 33328726)
1. Chronic Rhinosinusitis with Nasal Polyps: Targeting IgE with Anti-IgE Omalizumab Therapy.
Kariyawasam HH; James LK
Drug Des Devel Ther; 2020; 14():5483-5494. PubMed ID: 33328726
[TBL] [Abstract][Full Text] [Related]
2. Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status.
Gevaert P; Mullol J; Saenz R; Ko J; Steinke JW; Millette LA; Meltzer EO
Ann Allergy Asthma Immunol; 2024 Mar; 132(3):355-362.e1. PubMed ID: 37951571
[TBL] [Abstract][Full Text] [Related]
3. Omalizumab for chronic rhinosinusitis.
Brañes R; Rosenbaum A; Callejas C; Winter M
Medwave; 2018 Nov; 18(7):e7347. PubMed ID: 30507897
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.
Gevaert P; Omachi TA; Corren J; Mullol J; Han J; Lee SE; Kaufman D; Ligueros-Saylan M; Howard M; Zhu R; Owen R; Wong K; Islam L; Bachert C
J Allergy Clin Immunol; 2020 Sep; 146(3):595-605. PubMed ID: 32524991
[TBL] [Abstract][Full Text] [Related]
5. Omalizumab treats chronic rhinosinusitis with nasal polyps and asthma together-a real life study.
Bidder T; Sahota J; Rennie C; Lund VJ; Robinson DS; Kariyawasam HH
Rhinology; 2018 Mar; 56(1):42-45. PubMed ID: 29288573
[TBL] [Abstract][Full Text] [Related]
6. IgE directly affects eosinophil migration in chronic rhinosinusitis with nasal polyps through CCR3 and predicts the efficacy of omalizumab.
Yu J; Yan B; Shen S; Wang Y; Li Y; Cao F; Xiong W; Piao Y; Hu C; Sun Y; Zhang L; Wang C
J Allergy Clin Immunol; 2024 Feb; 153(2):447-460.e9. PubMed ID: 37922997
[TBL] [Abstract][Full Text] [Related]
7. [A real world study of anti-IgE monoclonal antibody in the treatment of allergic united airway disease].
Sui HJ; Zhen Z; Wang QG; Cong TC; Huang JJ; Hu Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Feb; 57(2):273-280. PubMed ID: 36797588
[No Abstract] [Full Text] [Related]
8. The role of omalizumab in the treatment of chronic rhinosinusitis with nasal polyposis.
Aldinger JP; Dobyns T; Lam K; Han JK
Expert Opin Biol Ther; 2021 Sep; 21(9):1143-1149. PubMed ID: 34334061
[No Abstract] [Full Text] [Related]
9. IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy.
Humbert M; Bousquet J; Bachert C; Palomares O; Pfister P; Kottakis I; Jaumont X; Thomsen SF; Papadopoulos NG
J Allergy Clin Immunol Pract; 2019; 7(5):1418-1429. PubMed ID: 30928481
[TBL] [Abstract][Full Text] [Related]
10. Broad IgG repertoire in patients with chronic rhinosinusitis with nasal polyps regulates proinflammatory IgE responses.
Shamji MH; Thomsen I; Layhadi JA; Kappen J; Holtappels G; Sahiner U; Switzer A; Durham SR; Pabst O; Bachert C
J Allergy Clin Immunol; 2019 Jun; 143(6):2086-2094.e2. PubMed ID: 30763592
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.
De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA
Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739
[TBL] [Abstract][Full Text] [Related]
12. Chronic rhinosinusitis with nasal polyps: mechanistic insights from targeting IL-4 and IL-13 via IL-4Rα inhibition with dupilumab.
Kariyawasam HH
Expert Rev Clin Immunol; 2020 Dec; 16(12):1115-1125. PubMed ID: 33148074
[No Abstract] [Full Text] [Related]
13. The Role of Biologics in the Treatment of Nasal Polyps.
Franzese CB
Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452
[TBL] [Abstract][Full Text] [Related]
14. Omalizumab versus intranasal steroids in the post-operative management of patients with allergic fungal rhinosinusitis.
Mostafa BE; Fadel M; Mohammed MA; Hamdi TAH; Askoura AM
Eur Arch Otorhinolaryngol; 2020 Jan; 277(1):121-128. PubMed ID: 31552526
[TBL] [Abstract][Full Text] [Related]
15. Biologics for chronic rhinosinusitis with nasal polyps.
Bachert C; Zhang N; Cavaliere C; Weiping W; Gevaert E; Krysko O
J Allergy Clin Immunol; 2020 Mar; 145(3):725-739. PubMed ID: 32145872
[TBL] [Abstract][Full Text] [Related]
16. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
Patel GB; Peters AT
Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
[TBL] [Abstract][Full Text] [Related]
17. Local fungus-specific Immunoglobulin E production in chronic rhinosinusitis with nasal polyps.
Ohki Y; Okamoto Y; Iinuma T; Yamamoto H; Toyotome T; Yahiro M; Yonekura S; Sakurai D; Kamei K
Rhinology; 2020 Apr; 58(2):136-144. PubMed ID: 31904030
[TBL] [Abstract][Full Text] [Related]
18. Allergic conversion of protective mucosal immunity against nasal bacteria in patients with chronic rhinosinusitis with nasal polyposis.
Takeda K; Sakakibara S; Yamashita K; Motooka D; Nakamura S; El Hussien MA; Katayama J; Maeda Y; Nakata M; Hamada S; Standley DM; Hayama M; Shikina T; Inohara H; Kikutani H
J Allergy Clin Immunol; 2019 Mar; 143(3):1163-1175.e15. PubMed ID: 30053529
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody therapy in sinonasal disease.
Chiarella SE; Sy H; Peters AT
Am J Rhinol Allergy; 2017 Mar; 31(2):93-95. PubMed ID: 28281440
[TBL] [Abstract][Full Text] [Related]
20. Improving predictability of IgE-high type 2 chronic sinusitis with nasal polyps in the biologic era.
Heffernan A; Phulka J; Thamboo A
J Otolaryngol Head Neck Surg; 2022 May; 51(1):22. PubMed ID: 35606866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
